Related Experiment Video
Updated: May 27, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
ATM-mediated DNA damage signals mediate immune escape through integrin-αvβ3-dependent mechanisms
Masahisa Jinushi1, Shigeki Chiba, Muhammad Baghdadi
1Research Center for Infection-Associated Cancer, Institute for Genetic Medicine, Hokkaido University, Tokyo, Japan.
Abstract:
Although the tumor microenvironment plays a critical role in tumor progression and metastasis, the relationship between chemotherapy resistance and modulation of the tumor microenvironment remains unclear. Here, we report a novel mechanism showing how constitutive DNA damage signals in therapy-resistant tumor cells suppress antitumor immunity in an integrin-αvβ3-dependent manner. Integrin-αvβ3 was upregulated on various therapy-resistant tumor cells through chronic activation of ATM/Chk2-and NFκB-mediated pathways. Inhibiting tumor-specific expression of integrin-αvβ3 improved therapeutic responses to anticancer drugs by stimulating endogenous host immune systems. Mechanistic investigations revealed that tumor-specific integrin-αvβ3 expression targeted dendritic cells, facilitating their ability to phagocytose viable therapy-resistant tumor cells and thereby impaired their ability to cross-prime antigen-specific T lymphocytes. Together, our results clarify the detrimental effects of constitutive DNA damage signals to chemosensitivity and antitumor immunity. Furthermore, these findings suggest that integrin-αvβ3 targeting may benefit patients' refractory to current anticancer regimens by defeating DNA damage signaling-induced immune escape.
Insights
Therapy-resistant tumors suppress immunity via DNA damage signals, mediated by integrin-αvβ3. Targeting this molecule enhances chemotherapy effectiveness by boosting the host immune system.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- The tumor microenvironment significantly influences cancer progression and metastasis.
- The interplay between chemotherapy resistance and tumor microenvironment modulation is not fully understood.
Purpose of the Study:
- To elucidate a novel mechanism by which constitutive DNA damage signals in therapy-resistant cells suppress antitumor immunity.
- To investigate the role of integrin-αvβ3 in this process and its potential as a therapeutic target.
Main Methods:
- Investigated integrin-αvβ3 upregulation in therapy-resistant tumor cells via ATM/Chk2 and NFκB pathways.
- Assessed the impact of inhibiting integrin-αvβ3 on therapeutic responses and host immune stimulation.
- Examined the interaction between integrin-αvβ3 and dendritic cells in T lymphocyte cross-priming.
Main Results:
- Constitutive DNA damage signals in therapy-resistant tumor cells suppress antitumor immunity in an integrin-αvβ3-dependent manner.
- Integrin-αvβ3 is upregulated on resistant cells through ATM/Chk2 and NFκB pathways.
- Inhibition of integrin-αvβ3 enhanced chemotherapy efficacy by stimulating the immune system.
- Integrin-αvβ3 impairs dendritic cell function, hindering T cell priming against viable tumor cells.
Conclusions:
- Clarified the detrimental effects of DNA damage signaling on chemosensitivity and antitumor immunity.
- Suggests integrin-αvβ3 targeting as a potential strategy to overcome immune escape in patients resistant to current anticancer therapies.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Cancer Cell Migration through Invadopodia
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

